AMGEN BCG MATRIX TEMPLATE RESEARCH Energy They consistently secure significant funding

They consistently secure significant funding from the NIH

and care managers is crucial for patient care

Metric 2025 Value MSSP revenue $80

Product Improvement: Enhancing existing offerings

a 2024 study showed 15% of blockchain partnerships yielded minimal ROI

AMGEN BCG MATRIX TEMPLATE RESEARCH Energy They consistently secure significant fundingActionable Strategy Starts Here Amgen's BCG Matrix highlights where flagship biologics act as Stars with high growth and share, while mature therapies like certain oncology products function as Cash Cows fueling R&D; some smaller pipeline assets sit in Question Marks needing capital decisions, and legacy generics face marginal Dog status. This snapshot helps prioritize investment, divestment, or development choices. Dive deeper into this company's BCG